Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974919 | 0.84 | TDP1 (0.42) | ALDH1A1TDP1 | |
| SCHEMBL29807846 | 0.84 | TDP1 (0.42) | ALDH1A1TDP1 | |
| SCHEMBL10526514 | 0.69 | CYP2A6 (0.39) | ALDH1A1TDP1 | |
| SCHEMBL985929 | 0.68 | TDP1 (0.42) | ALDH1A1TDP1 | |
| SCHEMBL29953658 | 0.68 | TDP1 (0.42) | ALDH1A1TDP1 | |
| SCHEMBL3424114 | 0.67 | GRM2 (0.39) | ALDH1A1 | |
| SCHEMBL12887731 | 0.65 | CYP1A2 (0.35) | ALDH1A1TDP1 | |
| SCHEMBL8148931 | 0.65 | CYP3A4 (0.46) | ALDH1A1 | |
| SCHEMBL12126083 | 0.65 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL12678959 | 0.65 | ALDH1A1 (0.35) | ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9130178-B2 | Oligomers of isonitrile-metal complexes as triplet emitters for OLED applications | MERCK PATENT GMBH (DE) | 2015-09-08 | — | — | US | disclosed |
| US-20100141120-A1 | Oligomers of Isonitrile-Metal Complexes as Triplett Emitters for OLED Applications | NOVALED AG (DE) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100141120-A1 | Oligomers of Isonitrile-Metal Complexes as Triplett Emitters for OLED Applications | OCIAD1, OCIAD2, OSTC | ALDH1A1 1708/4885TDP1 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.